AbbVie Inc. Peer Comparison
| Metric | Value | Ranking | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $327.9 Billion | 3/8 | LLY $888.7B |
JNJ $396.3B |
ABBV $327.9B |
MRK $286.5B |
AMGN $177.4B |
PFE $165.2B |
GILD $103.5B |
BMY $97.8B |
| Gross Margin | 67% | 5/8 | MRK 81% |
LLY 81% |
JNJ 79% |
GILD 78% |
ABBV 67% |
PFE 62% |
AMGN 61% |
BMY 56% |
| Profit Margin | 11% | 6/8 | MRK 30% |
LLY 26% |
GILD 23% |
JNJ 21% |
BMY 14% |
ABBV 11% |
AMGN 9% |
PFE 0% |
| EBITDA margin | 41% | 4/8 | GILD 49% |
BMY 42% |
LLY 42% |
ABBV 41% |
MRK 41% |
JNJ 29% |
PFE 27% |
AMGN 23% |
| Quarterly Revenue | $12.3 Billion | 4/8 | JNJ $22.4B |
MRK $15.8B |
PFE $13.3B |
ABBV $12.3B |
BMY $12.2B |
LLY $11.3B |
AMGN $8.4B |
GILD $6.9B |
| Quarterly Earnings | $1.4 Billion | 6/8 | MRK $4.8B |
JNJ $4.7B |
LLY $3.0B |
BMY $1.7B |
GILD $1.6B |
ABBV $1.4B |
AMGN $746.0M |
PFE $24.0M |
| Quarterly Free Cash Flow | $3.8 Billion | 2/8 | JNJ $4.7B |
ABBV $3.8B |
MRK $2.2B |
AMGN $2.2B |
BMY $2.1B |
GILD $1.2B |
LLY $63.4M |
PFE -$2.4B |
| Trailing 4 Quarters Revenue | $54.4 Billion | 4/8 | JNJ $86.6B |
MRK $61.4B |
PFE $55.6B |
ABBV $54.4B |
BMY $46.5B |
LLY $38.9B |
AMGN $30.9B |
GILD $27.8B |
| Trailing 4 Quarters Earnings | $6.0 Billion | 3/8 | JNJ $22.4B |
MRK $15.8B |
PFE $13.3B |
ABBV $12.3B |
BMY $12.2B |
LLY $11.3B |
AMGN $8.4B |
GILD $6.9B |
| Quarterly Earnings Growth | 473% | 1/8 | ABBV 473% |
MRK 69% |
LLY 68% |
GILD 54% |
JNJ -9% |
BMY -19% |
AMGN -46% |
PFE -99% |
| Annual Earnings Growth | -22% | 3/8 | JNJ 670% |
LLY 27% |
ABBV -22% |
AMGN -68% |
GILD -74% |
MRK -81% |
PFE -114% |
BMY -174% |
| Quarterly Revenue Growth | 1% | 6/8 | AMGN 20% |
BMY 9% |
MRK 9% |
GILD 5% |
PFE 4% |
ABBV 1% |
LLY 0% |
JNJ -12% |
| Annual Revenue Growth | -6% | 6/8 | LLY 86% |
AMGN 22% |
MRK 10% |
GILD 8% |
BMY 3% |
ABBV -6% |
JNJ -13% |
PFE -18% |
| Cash On Hand | $18.1 Billion | 2/8 | JNJ $24.9B |
ABBV $18.1B |
AMGN $9.3B |
BMY $6.3B |
MRK $5.7B |
LLY $3.2B |
GILD $2.8B |
PFE $1.1B |
| Short Term Debt | $10.2 Billion | 2/8 | PFE $11.9B |
ABBV $10.2B |
JNJ $9.9B |
AMGN $5.5B |
LLY $5.2B |
BMY $3.7B |
MRK $3.1B |
GILD $1.8B |
| Long Term Debt | $63.8 Billion | 1/8 | ABBV $63.8B |
PFE $57.5B |
AMGN $57.1B |
BMY $48.9B |
JNJ $31.6B |
MRK $31.1B |
LLY $23.7B |
GILD $21.5B |
| PE | 54.72 | 5/8 | MRK 124.26 |
LLY 121.04 |
GILD 98.32 |
AMGN 56.66 |
ABBV 54.72 |
JNJ 10.42 |
PFE -1.00 |
BMY -1.00 |
| PS | 6.03 | 2/8 | LLY 22.83 |
ABBV 6.03 |
AMGN 5.74 |
MRK 4.67 |
JNJ 4.58 |
GILD 3.72 |
PFE 2.97 |
BMY 2.10 |
| PB | 40.75 | 2/8 | LLY 65.17 |
ABBV 40.75 |
AMGN 29.93 |
MRK 7.09 |
BMY 5.73 |
GILD 5.69 |
JNJ 5.54 |
PFE 1.88 |
| PC | 18.15 | 6/8 | LLY 275.68 |
PFE 157.07 |
MRK 50.53 |
GILD 37.35 |
AMGN 19.07 |
ABBV 18.15 |
JNJ 15.93 |
BMY 15.54 |
| Liabilities to Equity | 17.59 | 1/8 | ABBV 17.59 |
AMGN 14.34 |
BMY 4.56 |
LLY 4.29 |
GILD 1.94 |
MRK 1.62 |
JNJ 1.53 |
PFE 1.46 |
| ROA | 0.04 | 3/8 | JNJ 21% | LLY 10% | ABBV 4% | AMGN 3% | GILD 2% | MRK 2% | PFE -1% | BMY -7% |
| ROE | 0.75 | 1/8 | ABBV 75% |
LLY 54% |
JNJ 53% |
AMGN 53% |
GILD 6% |
MRK 6% |
PFE -3% |
BMY -38% |
| Current Ratio | 1.06 | 8/8 | PFE 1.69 |
JNJ 1.65 |
MRK 1.62 |
GILD 1.51 |
LLY 1.23 |
BMY 1.22 |
AMGN 1.07 |
ABBV 1.06 |
| Quick Ratio | 0.13 | 2/8 | MRK 124.26 |
LLY 121.04 |
GILD 98.32 |
AMGN 56.66 |
ABBV 54.72 |
JNJ 10.42 |
PFE -1.00 |
BMY -1.00 |
| Long Term Debt to Equity | 7.97 | 2/8 | AMGN} 9.64 |
ABBV} 7.97 |
BMY} 2.87 |
LLY} 1.75 |
GILD} 1.18 |
MRK} 0.77 |
PFE} 0.66 |
JNJ} 0.44 |
| Debt to Equity | 9.24 | 2/8 | AMGN 10.57 |
ABBV 9.24 |
BMY 3.17 |
LLY 2.13 |
GILD 1.28 |
MRK 0.85 |
PFE 0.79 |
JNJ 0.58 |
| Burn Rate | 4.84 | 2/8 | BMY 5.24 |
ABBV 4.84 |
AMGN 3.18 |
PFE 0.20 |
MRK -2.06 |
LLY -4.43 |
GILD -9.24 |
JNJ -26.00 |
| Cash to Cap | 0.06 | 1/8 | ABBV 0.06 |
BMY 0.06 |
JNJ 0.06 |
AMGN 0.05 |
GILD 0.03 |
MRK 0.02 |
PFE 0.01 |
LLY 0.00 |
| CCR | 2.81 | 2/8 | AMGN 2.98 |
ABBV 2.81 |
BMY 1.23 |
JNJ 0.99 |
GILD 0.74 |
MRK 0.47 |
LLY 0.02 |
PFE -100.79 |
| EV to EBITDA | 75.82 | 3/8 | LLY} 193.78 |
AMGN} 120.85 |
ABBV} 75.82 |
PFE} 64.72 |
JNJ} 63.95 |
MRK} 48.60 |
GILD} 36.70 |
BMY} 28.28 |
| EV to Revenue | 7.06 | 3/8 | LLY 23.49 |
AMGN 7.47 |
ABBV 7.06 |
MRK 5.13 |
JNJ 4.77 |
GILD 4.46 |
PFE 4.20 |
BMY 3.13 |